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Abstract
Background: Cardiac involvement in beta-thalassemia major patients is an important cause of mortality. Therefore, in these pa-
tients, timely diagnosis of cardiac disorder is essential.
Objectives: The present study aimed at determining the association between cardiac iron overload and fragmented QRS (fQRS).
Methods: This cross-sectional study was conducted on 40 β-TM patients, aged 5 - 40 years. The presence of fQRS was evaluated in
12-lead surface electrocardiograms. Cardiac T2* MRI was performed to determine the iron overload. The patients were divided into
four groups of chelation therapy.
Results: The mean age of patients was reported to be 22.50 ± 6.75 years. The groups showed no significant difference regarding
gender, age, or left ventricular ejection fraction. The presence of fQRS was detected in 10 patients (25%), while T2* value was lower
than 20 ms in 10 patients (25%). The mean age of patients with and without fQRS was 26.23± 2.71 and 19.40± 2.61 years, respectively
(P = 0.001). The univariate analysis indicated that fQRS had a significant relationship with cardiac iron overload (OR = 5; 95% CI: 1.04
- 23.99; P < 0.044). The multiple logistic regression analysis represented a significant association between iron overload and fQRS
(OR = 5.556; 95% CI: 1.027 - 30.049). The sensitivity and specificity of the fQRS against MRI were equal to 50% and 83.3% respectively.
Conclusions: The absence of fQRS on ECGs could be a good predictor of the lack of cardiac iron overload inβ-TM patients. The results
showed that fQRS might indicate the no need for close monitoring for cardiac overload with cardiac MRI and aggressive chelation
therapy.
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1. Background
Beta-thalassemia major (β-TM) is recognized as a com-
mon monogenic disorder, reducing globin synthesis. Fre-
quent blood transfusions are necessary for β-TM patients
due to deep anemia associated with unsuccessful erythro-
poiesis. Cardiac iron overload in these patients is recog-
nized as the most important cause of cardiac arrhythmias
(1, 2). To evaluate cardiac iron load, it is suggested to reg-
ularly measure cardiac magnetic resonance (MR) and T2*
value (3, 4). However, since MRI is a costly and complex
method for early detection of cardiac disorders, physicians
are seeking more practical approaches.
Cardiac iron overload is related to non-homogeneous
myocardial activation in β-TM patients. Fragmented QRS
(fQRS) is described as a suitable myocardial scar marker,
measured by 12-lead electrocardiograms (ECGs). It is de-
fined as additional spikes within the QRS complex, repre-
senting a conduction delay due to inhomogeneous ventric-
ular activation, resulting from a myocardial scar. Evidence
suggests that fQRS is related to ventricular tachyarrhyth-
mia (5, 6). This arrhythmic marker is mainly used for is-
chemic etiologies, although it has been frequently mea-
sured in patients with non-ischemic cardiac diseases, espe-
cially systemic diseases with cardiac involvement. Accord-
ing to recent research, the presence of fQRS on surface ECGs
is indicative of disorders, resulting in non-homogeneous
myocardial activation (4).
2. Objectives
The present study aimed at determining the correla-
tion of fQRS in non-homogeneous cardiac activities (e.g., fi-
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brosis and scar formation) with cardiac iron overload (car-
diac T2* value) in β-TM patients. Moreover, the association




This cross-sectional study included 40 β-TM pa-
tients, aged 5 - 40 years, who were admitted to our
thalassemia center between September 2017 and April
2018. The sampling method was convenience. This study
was approved by Arak University of Medical Sciences
(IR.ARAKMU.REC.1395.208). Written informed consents
were also obtained from the parents or the patients.
3.2. Eligibility
All the patients regularly received iron chelators and
blood transfusions. We divided the patients into four
groups: deferiprone, deferasirox, deferoxamine, and de-
feriprone + deferoxamine. The exclusion criteria were as
follows: hypertension; diabetes mellitus; ischemic heart
disease; and smoking.
3.3. Electrocardiographic and Cardiac MRI Measurements
The presence of fQRS was examined on 12-lead surface
ECGs. The pattern of fQRS was described as the identifica-
tion of different RSR’ patterns in the absence or presence
of Q wave in two nearby derivations; additional R wave or
notching in the nadir of R or S wave; or the presence of
more than one R wave in the absence of typical bundle
branch block. Standard 12-lead ECGs were examined with-
out any magnification. If a detectable signal was found
in particular lead complexes, fragmentations were identi-
fied. Also, fQRS was considered to be present if it was found
in two lateral, anterior, or inferior leads. In addition, car-
diac iron overload, which was defined as T2* value below
20 ms, was examined using cardiac T2* MRI. The fQRS eval-
uated by one pediatric cardiology and the cardiac MRI re-
ported by one radiologist who was expert in cardiac MRI.
The pediatric cardiologist did not aware about the Cardiac
MRI reports.
3.4. Statistical Methods
For data analysis was performed with the IBM SPSS ver-
sion 23 for Windows (IBM SPSS Inc, Chicago, IL, USA). Fre-
quency and percentage were measured to present the cat-
egorical variables. For comparison of categorical variables
were used chi-square and Fisher’s exact tests, while inde-
pendent samples t-test was applied for continuous vari-
ables. In addition, the risk factors were identified based on
multiple logistic regression. Also, we have measured confi-
dence intervals (95% CI) as well as the sensitivity and speci-
ficity of the fQRS against MRI. The P value less than 0.05 was
regarded as statistical significant.
4. Results
A total of 40 β-TM patients were evaluated, including
17 men. The patients’ mean age was reported to be 22.45 ±
6.75 years. Patients with and without cardiac involvement
showed no significant difference regarding gender, age, or
left ventricular ejection fraction (Table 1).
The association between cardiac T2* value and fQRS on
ECGs was confirmed. Based on the findings, fQRS was de-
tected in 10 patients (25%), while T2* value was below 20
ms in 10 patients (25%). The mean age of samples with and
without fQRS was 26.80 ± 6.34 and 21.00 ± 6.33 years, re-
spectively (P = 0.017). The groups with and without fQRS
were not significantly different regarding the left ventric-
ular ejection.
Sensitivity and specificity of the fQRS against MRI was
equal to 50% and 83.3% respectively. The association of
fQRS with cardiac iron overload was examined using logis-
tic regression analysis. A significant correlation was found
between these variables in the univariate analysis (OR: 5;
95% CI: 1.04 - 23.99; P < 0.044). Also, the importance of
iron chelators was determined in a univariate analysis. The
patients who received deferiprone showed major cardiac
involvement in comparison with patients receiving other
chelators (Table 2). The univariate analysis indicated that
patients with fQRs had major cardiac involvement (Table
3).
According to the multiple logistic regression, fQRS had
a significant correlation with cardiac iron overload There-
fore, detection of fQRS inβ-TM patients can predict cardiac
iron overload (Table 4).
5. Discussion
In 12-lead ECGs, a suitable marker of the myocardial
scar is fQRS, which is described as an additional spike of
QRS complexes without bundle branch block. There are
multiple RSR’ patterns in the inferior or middle precordial
leads. Our findings represented that fQRS on surface ECGs
is indicative of increased cardiac iron overload only in half
of β-TM patients and the absence of fQRS is an excellent
predictor for good situation cardiac. Previous studies show
that iron accumulation mainly occurs in the myocardium.
Generally, for the measurement of iron overload, it is sug-
gested to determine cardiac MR and T2* value.
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Table 1. Demographics of Patients with and without Cardiac Involvement
Cardiac MR T2* < 20 ms (N = 10) Cardiac MR T2* > 20 ms (N = 30) P Value
Age, y 26.40 ± 5.64 21.13 ± 6.65 0.031*
Gender, F/M 6/4 17/13 0.853
Hemoglobin, g/dL 9.07 ± 0.52 9.38 ± 0.79 0.258
White blood cell count, 103 /mm3 8.67 ± 4.13 7.12 ± 4.34 0.329
Platelet, 103 /mm3 408 ± 10 425 ± 87 0.302
fQRS, No. (%) 5 (50) 5 (16.7) 0.035
T2* value 15.27 ± 4.22 27.53 ± 5.14 0.0001*
Left ventricular end diastolic diameter, mm 48.12 ± 4.67 47.73 ± 3.98 0.798
Left ventricular end systolic diameter, mm 32.11 ± 3.67 31.45 ± 2.57 0.532
Ejection fraction 54.67 ± 10.45 55.34 ± 8.71 0.842
Abbreviations: fQRS, fragmented QRS
Table 2. The Correlation of Iron Chelators and Cardiac Involvement with fQRS
With fQRS (N = 10) Without fQRS (N =
30)
P Value
Age 26.80 ± 6.34 21.00 ± 6.33 0.017
Deferiprone 5 1 0.002*




Deferasirox 2 11 0.451
Table 3. The Association Between Cardiac Iron Overload and fQRS
With fQRS (N = 10) Without fQRS (N = 30) P Value
T2* < 20 ms 8 0 0.0001*
T2* > 20 ms 2 28 0.0001*
Table 4. Multiple Logistic Regression Analysis of Cardiac T2* MR
OR 95% CI P Value
Ferritin 1.001 1.001 - 1.002 0.105
fQRS 5.556 1.027 - 30.049 0.046*
Hemoglobin 0.600 0.203 - 1.777 0.357
Abbreviations: fQRS, fragmented QRS
Cardiac iron overload seems to interrupt or block my-
ocardial electrical conduction and lead to myocardial con-
traction disorders. Early stages of the disease are associ-
ated with bradycardia, changes in the ST-T segment, pre-
mature ventricular and atrial systoles, left ventricular hy-
pertrophy, and first-degree atrioventricular blockade. On
the other hand, complete or second-degree atrioventric-
ular blockade, premature atrial and ventricular contrac-
tions, and supraventricular tachycardia may occur in the
late stages. Previous findings suggest that slow conduction
in cardiac muscles prolongs QT and PR intervals (7).
The conditions of are associated with non-
homogeneous myocardial activation (e.g., fibrosis), can
produce fQRS on ECGs. According to previous findings,
fQRS represents conduction delays associated with inho-
mogeneous ventricular activation because of myocardial
scar. The evidence suggests that low T2* values represent
disorders in the myocardial conduction system. In this
regard, a study on 652 β-TM patients showed the risk of
arrhythmia in patients with cardiac T2* values below 20
ms. The risk of cardiac insufficiency was also reported
in cases with T2* values below 10 ms (8). In the present
study, we assessed fQRS and there was only 50% patients
at cardiac T2* values below 20 ms. Our finding was varied
according to the previous study.in other words, based on
our findings; it was found that absence was much more
valuable and useful.
The incidence of fQRS increased with age in the present
study, which is suggestive of time-dependent fibrosis. In
another study, ventricular late potential (VLP) was found
to be more common in β-TM patients. Also, in patients
with VLP, premature ventricular systoles, as well as tran-
sient ventricular tachycardia, were frequent (9). Normally,
β-TM patients, receiving inadequate chelation therapy, ex-
perience cardiac insufficiency. It is known that excess free
iron, which is undeposited in the lysosomes, has toxic ef-
fects on the cells. Moreover, it interrupts redox reactions,
as well as gene changes, and triggers free radical forma-
tion, resulting in the oxidative impairment of membranes.
Consequently, cardiac dysfunction occurs due to impaired
mitochondrial energy production (10, 11).
In β-TM patients, the most important cause of mor-
tality is cardiac insufficiency; therefore, timely detection
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of cardiac problems and treatment modifications are of
great significance. In these patients, non-uniformity of
the left ventricular wall is an early indicator of cardiac in-
volvement, despite intact global ventricular function. In
the present study, we first assessed cardiac function using
M-mode echocardiography. No cardiac dysfunction was
found on traditional echocardiography. Next, the partic-
ipants were classified into two groups, and ejection frac-
tion and ventricular diameters were measured. The groups
showed no significant difference, except for age, which
might indicate a time-dependent process in these patients
(Table 1).
Electrical heterogeneity in the ventricular my-
ocardium may account for the inhomogeneous depo-
sition, oxidative mechanisms, and localized fibrous
replacement. Nevertheless, the mechanisms of fQRS de-
velopment remain unclear, although fQRS seems to be
associated with non-homogeneous depolarization in dis-
orders, such as fibrosis, myocardial scar, and ischemia (12).
Previous research suggests fQRS evaluation as a helpful
tool for the assessment of cardiac risk and arrhythmic
events. Moreover, in another study on ST-segment ele-
vation myocardial infarction, fQRS on ECGs could help
identify high-risk patients (13, 14).
The association of cardiac iron overload with fQRS on
surface ECGs predicted based on our findings. On based
our study, 50% of patients with T2 less than 20 had abnor-
mal ECG, whereas in T2 more than 20 only 16% had an ab-
normality in ECG tracing. This finding suggested that ef-
fecting predictor fQRS is significant.
It is generally important to evaluate the emergence of
fQRS on surface ECGs during follow-ups in order to modify
the treatment regimens accordingly. Also, age was found
to have a significant association with low T2* and fQRS, sug-
gesting an absence of cardiac iron load with age. In an-
other study, delayed-enhancement cardiac MRI was used
to examine myocardial scars in 115 TM patients. Delayed-
enhancement regions were detected in 28 patients (24%),
26 of whom showed patchy fibrosis. Scar formation was
mostly found in older patients. Also, TM patients showed
more frequent myocardial fibrosis and necrosis, compared
with the normal population (15).
Regarding the type of iron chelators, fQRS was less
commonly detected in patients receiving deferoxamine or
deferasirox. In the present study, deferasirox (Exjade) and
deferoxamine were more suitable than other chelators,
and T2* values were above 20 ms (Table 5). Moreover, a
logistic regression analysis indicated a significant associa-
tion between fQRS and cardiac iron overload. The results
showed that cardiac iron overload was five times more
common among patients with fQRS.
Nermin Bayar et al found of total of 103 patients (mean
age 22.6 ± 6.6) with diagnosis of beta thalassemia major,
50 patients (48%), fQRS detected, 37 of them (74%), T2* val-
ues were found to below. the presence of fQRS, low T2*
value to predict the sensitivity of 86.0% and specificity of
78.3%, respectively (16). In our study, presence of fQRS was
50% in T2* value less than 20.
In the present study, fQRS was not observed in 28 pa-
tients with T2* values exceeding 20 ms. Univariate analy-
sis was used to determine the association between cardiac
involvement and fQRs. Increased iron overload was associ-
ated with a high incidence of fQRS. Also, the importance of
iron chelators in cardiac involvement was examined based
on the univariate analysis. The results revealed the high
incidence of cardiac involvement in patients receiving de-
feriprone, compared with others. Iron deposition was not
significantly different between the recipients of different
chelators. In our study, it was found that the combination
of deferiprone and deferoxamine is more suitable than
other chelators and that the presence of fQRS was less com-
mon in these patients.
Based on the multiple logistic regression analysis, car-
diac iron overload and fQRS were significantly correlated.
This finding suggests the high predictive value of fQRS
for cardiac iron overload in TM patients; in fact, cardiac
iron overload was 5.5 times more common among patients
with fQRS. Of course, we cannot express detecting fQRS in
ECG tracing is the only relating to iron overload.
However, we recommend performing cardiac imaging
based on the proposed protocols, to further studies and
long-term follow-up in patients with thalassemia major.
Therefore, the fQRS cannot substitute cardiac MRI and T2*
should still be done in all patients and fQRS only can be
considered if MRI cannot be done in such patients.
Finally, it should be kept in mind that fQRS can also oc-
cur for other causes, for example, cardiac ischemia related
to myocardial scar/myocardial ischemia or myocardial fi-
brosis.
The fQRS is to be a good predictor of cardiac events due
to CAD and patients with acute MI (17). Also in patients with
non-ischemic cardiomyopathy, fQRS is related to a degree
of fibrosis and dys-synchrony and influences the response
for CRT (1).
At result, we should considers other causes of fQRS
changes in patient thalassemia, such as fQRS is a marker of
myocardial scar in coronary artery disease (CAD), arrhyth-
mic events in non-ischemic cardiomyopathy, no ischemic
cardiomyopathy (NICM), arrhythmogenic right ventric-
ular dysplasia /cardiomyopathy (ARVD/C), Brugada syn-
drome, acquired long QT syndrome and cardiac sarcoido-
sis (18).
The fQRS has reported in case of mitral stenosis, de-
creased mitral valve area and also in patients with mitral
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Table 5. Iron Chelators Used for Patients with Cardiac Involvement
Deferiprone Deferoxamine Deferiprone + Deferoxamine Deferasirox (Exjade)
T2* < 20 ms 3 3 1 3
T2* > 20 ms 1 12 7 10
Presence of fQRS (n = 10) 5 2 1 2
Absence of fQRS (n = 30) 1 10 8 11
Abbreviations: fQRS, fragmented QRS
stenosis caused by rheumatic fever. Other causes of fQRS
were hypertrophic cardiomyopathy (HCM), left ventricular
non-compaction, heart failure associated with low EF, poor
NYHA functional class and increased pulmonary pressure
(19).
This finding shows that the presentation of fQRS is a
nonspecific finding, and its interpretation should only be
performed in the presence of clinical manifestations and
type of myocardial involvement.
5.1. Conclusions
The results showed that the absence of fQRS on surface
ECGs must be considered in β-TM patients to modify treat-
ments as well as aggressive chelation therapy. The absence
of fQRS could majorly predict that the cardiac iron over-
load did not happen. Therefore, absence of fQRS might
indicate the importance of no need for close monitoring
with cardiac MRI T2*, and aggressive chelation therapy.
5.2. Limitations
First, we could not evaluate the impact of fQRS on prog-
nosis, as we did not perform any follow-up studies. Second,
we could not conduct 24-hour Holter monitoring to deter-
mine rhythm disorders. Third, we could not use low-pass
filters to decrease the electrical and musculature noise
during 12-lead ECG recordings, and we did not examine
subclinical cardiac dysfunction, based on systolic and dias-
tolic phases of pulsed-wave Doppler echocardiography. Fi-
nally, the cardiologist was not blinded considering the pa-
tients’ general appearance.
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portance of Fragmented QRS in Evaluation of Cardiac Iron Burden, in
Patients with β-Thalassemia Major. J Am Coll Cardiol. 2013;62(18):C152.
doi: 10.1016/j.jacc.2013.08.451.
17. Wang DD, Buerkel DM, Corbett JR, Gurm HS. Fragmented QRS complex
has poor sensitivity in detecting myocardial scar. Ann Noninvasive
Electrocardiol. 2010;15(4):308–14. doi: 10.1111/j.1542-474X.2010.00385.x.
[PubMed: 20946552]. [PubMed Central: PMC6931930].
18. Das MK, Zipes DP. Fragmented QRS: A predictor of mortality and
sudden cardiac death. Heart Rhythm. 2009;6(3 Suppl):S8–14. doi:
10.1016/j.hrthm.2008.10.019. [PubMed: 19251229].
19. Jain R, Singh R, Yamini S, Das MK. Fragmented ECG as a risk marker
in cardiovascular diseases. Curr Cardiol Rev. 2014;10(3):277–86. doi:
10.2174/1573403x10666140514103451. [PubMed: 24827794]. [PubMed
Central: PMC4040879].
6 Shiraz E-Med J. 2020; 21(8):e96612.
